Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis

Published:2022-09 Issue: Volume:51 Page:101545
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Yao Weiqi^ORCID,Dong Haibo,Qi Ji,Zhang Yu,Shi Lei^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference48 articles.

1. World Health Organization (WHO) Coronavirus (COVID-19) Dashboard. 9 December 2021. https://covid19.who.int/. Accessed 10 December 2021.

2. Coronavirus disease 2019; epidemiology and recommendations;Ghelichi-Ghojogh;J Prev Epidemiol,2020

3. Severe covid-19;Berlin;N Engl J Med,2020

4. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

5. Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells;Shu;Stem Cell Res Ther,2020

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibronectin and vitronectin alleviate adipose-derived stem cells senescence during long-term culture through the AKT/MDM2/P53 pathway;Scientific Reports;2024-06-20

2. Controversies regarding transplantation of mesenchymal stem cells;World Journal of Transplantation;2024-06-18

3. Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life;Stem Cell Research & Therapy;2024-04-19

4. Mesenchymal Stem Cells Induce an Immunosuppressive Microenvironment in Pituitary Tumors;The Journal of Clinical Endocrinology & Metabolism;2024-04-09

5. Mesenchymal Stem Cell Priming: Potential Benefits of Administration of Molecular Hydrogen;Pharmaceuticals;2024-04-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3